Although PARIS targets have been studied at the transcriptomic level in SH-SY5Y cells [12], PD relevant transcriptomic signature of dopaminergic neurons have not been determined in vivo owing to the lack of available mouse models. This evidence concerns the gene ZNF746 and Parkinson disease.